Post-biopsy cavity treatment implants and methods
Abstract
An embodiment of a post-biopsy cavity treatment implant includes a first portion including a first porous matrix defining a first controlled pore architecture or crosslinking density, and a second portion coupled to the first portion. The second portion includes a second porous matrix that defines a second controlled pore architecture or a second crosslinking density that is different from the first controlled pore architecture or the first crosslinking density, causing the second portion to swell in a different manner than the first portion when the implant is placed in an aqueous environment.
Claims
exact text as granted — not AI-modified1 - 33 . (canceled)
34 . A method for mapping a lymphatic system following a cavity generating procedure, comprising:
providing a post-biopsy cavity treatment implant, the implant including a collagenous matrix having a non-uniform cross-linking density that is configured to cause the implant to swell non-uniformly when placed within an aqueous environment, the implant including a dye or a pigment contained therein; implanting the provided post-biopsy cavity treatment implant into the cavity; closing the cavity with the post-biopsy cavity treatment implant implanted therein; causing the dye/pigment to be released from the implant and to propagate through the lymphatic system, and visualizing the propagated dye/pigment in the lymphatic system using a selected visualization mode.
35 . The method of claim 34 , wherein the implant in the providing step includes a reservoir disposed within the collagenous matrix, the reservoir containing a volume of the dye/pigment and wherein the causing step includes a step of breaching the reservoir to release the dye/pigment.
36 . The method of claim 35 , wherein the breaching step includes a step of squeezing the implanted post-biopsy cavity treatment implant.
37 . The method of claim 34 , wherein the causing step includes a step of waiting for a predetermined period of time during which the implant degrades within the cavity and releases the dye/pigment.
38 . The method of claim 34 , wherein the at least one of dye and pigment is loaded within the collagenous matrix of the implant.
39 . The method of claim 34 , wherein visualizing mode in the visualizing step includes at least one of ultrasound, X-ray, MRI, elastography, microwave and the unaided eye.
40 - 73 . (canceled)Join the waitlist — get patent alerts
Track US2013289388A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.